| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/10/2002 | CN1344155A Transnasal transport/immunisation with highly adaptable carriers |
| 04/10/2002 | CN1343728A Natural plant polyose |
| 04/10/2002 | CN1343725A Human angiogenin-like protein and coding sequence and application thereof |
| 04/10/2002 | CN1343673A Thiophosphamino acid ester compound containing 3'-azido-deoxythymidine and its preparing process |
| 04/10/2002 | CN1343672A 3'-azido-deoxythymidine-5'-thiopyhosphamino acid ester compound and its preparing process |
| 04/10/2002 | CN1343522A Radioactive macroaggregate and its prepn. method |
| 04/10/2002 | CN1343521A Preparing box for polysaccharide compounding substance |
| 04/10/2002 | CN1343518A Efficacy and application of soft capsule or oily pill prepared by mixing tomato seed oil with rubin |
| 04/10/2002 | CN1343493A Application of N-gluco-N-bithiocarboxylic acid-L-amino acid sodium in repelling Pt |
| 04/10/2002 | CN1343492A Taxol-series compound anticancer medicines |
| 04/10/2002 | CN1343490A Sophoridine and its application in analgesic |
| 04/10/2002 | CN1343489A Percutaneous absorption type anticancer medicine to suppress hyperplasia and untoward differentiation of cells |
| 04/10/2002 | CN1082509C Camptothecin-skeleton compounds isolated from mappia foetida and use thereof as syntones for medicaments as well as therapeutical agents |
| 04/10/2002 | CN1082376C Anticancer medicine with two-way treating actions of eliminating pathogenic factor and supporting healthy energy |
| 04/09/2002 | US6369211 MAGE-3 peptides presented by HLA class II molecules |
| 04/09/2002 | US6369210 22012, human carboxypeptidase |
| 04/09/2002 | US6369209 Oligonucleotides having A-DNA form and B-DNA form conformational geometry |
| 04/09/2002 | US6369193 Contulakin-G, analogs thereof and uses therefor |
| 04/09/2002 | US6369100 Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids |
| 04/09/2002 | US6369099 Method of locking 1 α-OH of vitamin D compounds in axial orientation |
| 04/09/2002 | US6369096 Benzyloxy prodigiosine compounds |
| 04/09/2002 | US6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors |
| 04/09/2002 | US6369084 Prostaglandin mediated diseases |
| 04/09/2002 | US6369082 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 04/09/2002 | US6369070 Methods for inhibiting mrp1 |
| 04/09/2002 | US6369069 Cardiovascular disorders |
| 04/09/2002 | US6369056 Agonists and antagonists of the progesterone receptor; contraceptives; 6-(3-chlorophenyl)-4,4-dimethyl-1,4-dihydro -3-oxa-1,8-diaza-naphthalene-2-one and 6-chloro-4,4-dimethyl-1,4-dihydro-3-oxa-1,5-diaza-naphthalen-2-one |
| 04/09/2002 | US6369038 Closed antisense and sense oligonucleotides and their applications |
| 04/09/2002 | US6369034 For therapy of cancer, restenosis, and atherosclerosis |
| 04/09/2002 | US6368855 MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expression |
| 04/09/2002 | US6368853 A nucleic acid encoding a polypeptide ligand; tyrosine kinase containing immunoglobulin and epidermal growth factor homolog domains; therapy and diagnosis for angiogenesis in wound healing, inflammation or tumors |
| 04/09/2002 | US6368852 A peptide capable of inducing cytotoxic t lymphocytes, immune response; anticarcinogenic agents |
| 04/09/2002 | US6368842 An isolated nucleic acid; therapy for neuroblastomas in infant brains, uterus, lung, ovary adenocarcinomas and leukocytes |
| 04/09/2002 | US6368826 A nucleic acid sequence encoding an insulin receptor substrate; therapy and diagnosis for tumors, cellular proliferative disorders, and cancer |
| 04/09/2002 | US6368810 A monoclonal antibody; for diagnosis, prevention and therapy of inflammation and cancer |
| 04/09/2002 | US6368797 Determining the genotype at nucleotide 192 of a gene that is an indicator of an increased risk for alzheimer's disease by performing restriction enzyme digestion of an amplified product of the nucleic acid molecule |
| 04/09/2002 | US6368789 Screening methods to identify inhibitors of telomerase activity |
| 04/09/2002 | US6368608 Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 04/09/2002 | US6368605 Method for treating cancer with a neurotoxin to improve patient function |
| 04/09/2002 | US6368598 Administering complex of polyamine carrier, drug and connector |
| 04/09/2002 | US6368594 Pure polypeptide |
| 04/09/2002 | CA2228595C Novel water-soluble c-ring analogues of 20 (s)-camptothecin |
| 04/09/2002 | CA2215732C Quinazoline derivatives |
| 04/09/2002 | CA2142560C Acronycin analogues; process for preparing the same and pharmaceutical compositions containing them |
| 04/09/2002 | CA1341355C Production and use of il-6 |
| 04/06/2002 | CA2358179A1 Anti-inflammatory vectors |
| 04/04/2002 | WO2002027324A2 METHODS OF USE OF ALPHA-METHYLACYL-CoA RACEMASE IN HORMONE REFRACTORY AND METASTATIC PROSTATE CANCERS |
| 04/04/2002 | WO2002027318A1 Methods and compositions for screening modulators of lipid kinases |
| 04/04/2002 | WO2002027010A1 Xanthone compound |
| 04/04/2002 | WO2002026998A2 Hydrolases |
| 04/04/2002 | WO2002026997A2 Dsp-16 dual-specificity phosphatase |
| 04/04/2002 | WO2002026996A2 Regulation of human phosphatidylinositol-specific phospholipase c-like enzyme |
| 04/04/2002 | WO2002026982A2 Secreted human proteins |
| 04/04/2002 | WO2002026977A1 Host cell obtained by transferring vhl gene into cancer cell or embryonic stem cell and expressing |
| 04/04/2002 | WO2002026965A1 Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like |
| 04/04/2002 | WO2002026954A2 Truncated phosphodiesterase-7 polypeptides |
| 04/04/2002 | WO2002026950A2 Transferases |
| 04/04/2002 | WO2002026947A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 04/04/2002 | WO2002026946A2 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof |
| 04/04/2002 | WO2002026935A2 TGF-β INHIBITORS AND METHODS |
| 04/04/2002 | WO2002026929A2 Kini-3 motor protein and methods for its use |
| 04/04/2002 | WO2002026829A1 Method for the production of human antibodies, antibodies thus obtained and their use in therapy and diagnosis |
| 04/04/2002 | WO2002026825A2 G-protein coupled receptors |
| 04/04/2002 | WO2002026823A2 A novel human g-protein coupled receptor, hgprbmy7, expressed highly in spinal cord |
| 04/04/2002 | WO2002026822A2 Pumpcn compositions and uses thereof |
| 04/04/2002 | WO2002026819A2 Recombinant bcg vaccines for the prevention and treatment of cancer |
| 04/04/2002 | WO2002026809A1 A new polypeptide- transmembrane 35.31 containing epidermal growth factor-like repeating domain and the polynucleotide encoding it |
| 04/04/2002 | WO2002026802A2 M32404, a novel human trypsin and uses thereof |
| 04/04/2002 | WO2002026799A1 A novel polypeptide -human cytoplasmic dynein intermediated chain (ic) 9.35 and the polynucleotide encoding said polypeptide |
| 04/04/2002 | WO2002026798A1 A novel polypeptide -phosphatidic acid phosphatase 29.81 and the polynucleotide encoding said polypeptide |
| 04/04/2002 | WO2002026797A1 A novel polypeptide -human dehydrogenase 29.15 and the polynucleotide encoding said polypeptide |
| 04/04/2002 | WO2002026796A1 A novel polypeptide human growth factor receptor 14.3 and the polynucleotide encoding said polypeptide |
| 04/04/2002 | WO2002026782A2 Antiangiogenic polypeptides and methods for inhibiting angiogenesis |
| 04/04/2002 | WO2002026777A1 Peptide ligands for prostate specific antigen |
| 04/04/2002 | WO2002026774A2 Melanocortin receptor ligands |
| 04/04/2002 | WO2002026759A2 17α FLUOROALKYL STEROIDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS |
| 04/04/2002 | WO2002026757A2 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 04/04/2002 | WO2002026748A2 Metal complexes for use in medical and therapeutic applications |
| 04/04/2002 | WO2002026744A1 Mpc1001 derivatives |
| 04/04/2002 | WO2002026733A2 sHARMACEUTICALLY ACTIVE SULFONAMIDE DERIVATIVES BEARING BOTH LIPOPHILIC AND IONISABLE MOIETIES AS INHIBITORS OF PROTEIN JUNKINASES |
| 04/04/2002 | WO2002026730A2 Fluorinated quinolones as antimitotic and antitumor agents |
| 04/04/2002 | WO2002026729A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 04/04/2002 | WO2002026727A2 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/04/2002 | WO2002026724A1 Cyclized benzamide neurokinin antagonists for use in therapy |
| 04/04/2002 | WO2002026723A1 Compounds useful in the treatment of inflammatory diseases |
| 04/04/2002 | WO2002026717A2 Hydroxy acid integrin antagonists |
| 04/04/2002 | WO2002026716A2 Benzimidazoles and methods for use thereof in the treatment of cancer or viral infections |
| 04/04/2002 | WO2002026711A1 Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases |
| 04/04/2002 | WO2002026706A2 17-beta-hydroxysteroid dehydrogenase-ii inhibitors |
| 04/04/2002 | WO2002026704A1 2-thiocarbamoyloxy and 2-carbamoyloxy derivatives of cyclopentyl-heptan(ene)oic acid as therapeutic agents |
| 04/04/2002 | WO2002026703A1 Carbamic acid compounds comprising an ether linkage as hdac inhibitors |
| 04/04/2002 | WO2002026696A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 04/04/2002 | WO2002026279A1 E-ptfe foil impregnated with an encapsulated bioactive substance |
| 04/04/2002 | WO2002026227A1 Lactone integrin antagonists |
| 04/04/2002 | WO2002026220A2 Taxoid conjugates as antimitotic and antitumor agents |
| 04/04/2002 | WO2002026215A2 Thermogelling biodegradable aqueous polymer solution |
| 04/04/2002 | WO2002026214A1 Ion-strength independent sustained release pharmaceutical formulation |
| 04/04/2002 | WO2002026193A2 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas |
| 04/04/2002 | WO2002026192A2 Viruses targeted to hypoxic cells and tissues |
| 04/04/2002 | WO2002014281A8 Pyridine derivatives as inhibitors of p38 |